How to buy Prelude Therapeutics Incorporated shares | $57.95

Own Prelude Therapeutics Incorporated shares in just a few minutes. Share price changes are updated daily.

Prelude Therapeutics Incorporated (PRLD) is a leading biotechnology business based in the US. It opened the day at $60.11 after a previous close of $57.96. During the day the price has varied from a low of $56.81 to a high of $60.33. The latest price was $57.95 (25 minute delay). Prelude Therapeutics Incorporated is listed on the NASDAQ and employs 68 staff. All prices are listed in US Dollars.

How to buy shares in Prelude Therapeutics Incorporated

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PRLD in this case.
  5. Research Prelude Therapeutics Incorporated shares. The platform should provide the latest information available.
  6. Buy your Prelude Therapeutics Incorporated shares. It's that simple.
The whole process can take as little as 15 minutes.

Prelude Therapeutics Incorporated share price

Use our graph to track the performance of PRLD stocks over time.

Prelude Therapeutics Incorporated shares at a glance

Information last updated 2021-03-11.
Open$60.11
High$60.33
Low$56.81
Close$57.95
Previous close$57.96
Change $-0.01
Change % -0.0173%
Volume 42,786
Information last updated 2021-04-23.
52-week range$23.693 - $95.375
50-day moving average $45.3297
200-day moving average $55.8213
Wall St. target price$62.5
Dividend yield N/A (0%)
Earnings per share (TTM) N/A
Promoted
eToro Free Stocks

Invest in Prelude Therapeutics Incorporated shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes

Fees for buying 10x Prelude Therapeutics Incorporated shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $200 £2.04
£410.59 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.87
£409.42 total
Capital at risk
Stake logo £0 £50 £2.07
£410.62 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.06
£424.61 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £14.15
£422.69 total
Capital at risk
Fineco logo £0 No minimum £4.09
£412.63 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £14.64
£423.18 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Prelude Therapeutics Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Prelude Therapeutics Incorporated price performance over time

Historical closes compared with the last close of $57.95

1 month (2021-04-19) 84.09%
3 months (2021-02-18) -24.02%
6 months (2020-11-17) 12.09%

Financials

Gross profit TTM $0
Return on assets TTM -29.93%
Return on equity TTM -49.67%
Profit margin 0%
Market capitalisation $1.9 billion

TTM: trailing 12 months

How to short and sell Prelude Therapeutics Incorporated shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "PRLD.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.7 million Prelude Therapeutics Incorporated shares held short by investors – that's known as the "short interest". This figure is 24.5% up from 1.4 million last month.

There are a few different ways that this level of interest in shorting Prelude Therapeutics Incorporated shares can be evaluated.

Short interest ratio (SIR)

Prelude Therapeutics Incorporated's "short interest ratio" (SIR) is the quantity of Prelude Therapeutics Incorporated shares currently shorted divided by the average quantity of Prelude Therapeutics Incorporated shares traded daily (recently around 223851.5625). Prelude Therapeutics Incorporated's SIR currently stands at 7.68. In other words for every 100,000 Prelude Therapeutics Incorporated shares traded daily on the market, roughly 7680 shares are currently held short.

However Prelude Therapeutics Incorporated's short interest can also be evaluated against the total number of Prelude Therapeutics Incorporated shares. In this case Prelude Therapeutics Incorporated's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Prelude Therapeutics Incorporated shares in existence, roughly 40 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Prelude Therapeutics Incorporated.

Find out more about how you can short Prelude Therapeutics Incorporated stock.

Prelude Therapeutics Incorporated share dividends

We're not expecting Prelude Therapeutics Incorporated to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site